Hakutulokset - Ben George

Tarkenna hakua
  1. 1
    Non-metastatic Pancreatic Cancer: Resectable, Borderline Resectable, and Locally Advanced-Definitions of Increasing Importance for the Optimal Delivery of Multimodality Therapy

    Non-metastatic Pancreatic Cancer: Resectable, Borderline Resectable, and Locally Advanced-Definitions of Increasing Importance for the Optimal Delivery of Multimodality Therapy Tekijä Douglas B. Evans, Ben George, Susan Tsai

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Editorial
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Immunogenomic Landscape Contributes to Hyperprogressive Disease after Anti-PD-1 Immunotherapy for Cancer

    Immunogenomic Landscape Contributes to Hyperprogressive Disease after Anti-PD-1 Immunotherapy for Cancer Tekijä Donghai Xiong, Yian Wang, Arun K. Singavi, Alexander C. Mackinnon, Ben George, Ming You

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Telemedicine Adoption during the COVID-19 Pandemic: Gaps and Inequalities

    Telemedicine Adoption during the COVID-19 Pandemic: Gaps and Inequalities Tekijä Jake Luo, Ling Tong, Bradley H. Crotty, Melek Somai, Bradley Taylor, Kristen Osinski, Ben George

    Julkaistu 2021
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Telemedicine and health disparities: Association between patient characteristics and telemedicine, in-person, telephone and message-based care during the COVID-19 pandemic

    Telemedicine and health disparities: Association between patient characteristics and telemedicine, in-person, telephone and message-based care during the COVID-19 pandemic Tekijä Ling Tong, Ben George, Bradley H. Crotty, Melek Somai, Bradley Taylor, Kristen Osinski, Jake Luo

    Julkaistu 2022
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    ALK fusions in the pan-cancer setting: another tumor-agnostic target?

    ALK fusions in the pan-cancer setting: another tumor-agnostic target? Tekijä Aditya Shreenivas, Filip Janků, Mohamed A. Gouda, Hui‐Zi Chen, Ben George, Shumei Kato, Razelle Kurzrock

    Julkaistu 2023
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-Analysis

    Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-Analysis Tekijä Anthony J. Zacharias, Thejus Jayakrishnan, Rahul Rajeev, William S. Rilling, James P. Thomas, Ben George, Fabian M. Johnston, T. Clark Gamblin, Kiran K. Turaga

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer

    Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer Tekijä Mohammed Aldakkak, Kathleen K. Christians, Ashley N. Krepline, Ben George, Paul S. Ritch, Bradley A. Erickson, Fabian M. Johnston, Douglas B. Evans, Susan Tsai

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Predictive biomarkers for hyper-progression (HP) in response to immune checkpoint inhibitors (ICI) – analysis of somatic alterations (SAs)

    Predictive biomarkers for hyper-progression (HP) in response to immune checkpoint inhibitors (ICI) – analysis of somatic alterations (SAs) Tekijä Arun K. Singavi, Sreedevi K. Menon, Deepak Kilari, Abdel Alqwasmi, Paul S. Ritch, James P. Thomas, Abel Martin, Carolyn Oxencis, Sayed Ali, Ben George

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer

    Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer Tekijä Jordan Kharofa, Susan Tsai, Tracy Kelly, Clint Wood, Ben George, Paul S. Ritch, Lauren Allison Wiebe, Kathleen K. Christians, Douglas B. Evans, Bradley A. Erickson

    Julkaistu 2014
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer

    The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer Tekijä Anirban P. Mitra, Arpit A. Almal, Ben George, David W. Fry, Peter F. Lenehan, Vincenzo Pagliarulo, Richard J. Côté, Ram H. Datar, William P. Worzel

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    <i>p53</i> Gene and Protein Status: The Role of <i>p53</i> Alterations in Predicting Outcome in Patients With Bladder Cancer

    <i>p53</i> Gene and Protein Status: The Role of <i>p53</i> Alterations in Predicting Outcome in Patients With Bladder Cancer Tekijä Ben George, Ram H. Datar, Lin Wu, Jie Cai, Nancy Patten, Stephen Beil, Susan Groshen, John P. Stein, Donald G. Skinner, Peter A. Jones, Richard J. Côté

    Julkaistu 2007
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreas Cancer: A New Treatment Paradigm?

    Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreas Cancer: A New Treatment Paradigm? Tekijä Kathleen K. Christians, Susan Tsai, Anna Mahmoud, Paul S. Ritch, James P. Thomas, Lauren Allison Wiebe, Tracy Kelly, Bradley A. Erickson, Huamin Wang, Douglas B. Evans, Ben George

    Julkaistu 2014
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Quantitative imaging for radiotherapy purposes

    Quantitative imaging for radiotherapy purposes Tekijä Oliver J. Gurney‐Champion, Faisal Mahmood, Marcel van Schie, Robert Julian, Ben George, M.E.P. Philippens, Uulke A. van der Heide, Daniela Thorwarth, Kathrine Røe Redalen

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    High-Grade Neuroendocrine Colorectal Carcinomas: A Retrospective Study of 100 Patients

    High-Grade Neuroendocrine Colorectal Carcinomas: A Retrospective Study of 100 Patients Tekijä Bruno Conte, Ben George, Michael J. Overman, Jeannelyn S. Estrella, Zhi-Qin Jiang, Amir Mehrvarz Sarshekeh, Renata Ferrarotto, Paulo M. Hoff, Asif Rashid, James C. Yao, Scott Kopetz, Arvind Dasari

    Julkaistu 2015
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Combined Effects of p53, p21, and pRb Expression in the Progression of Bladder Transitional Cell Carcinoma

    Combined Effects of p53, p21, and pRb Expression in the Progression of Bladder Transitional Cell Carcinoma Tekijä Sunanda Chatterjee, Ram H. Datar, David Youssefzadeh, Ben George, Peter J. Goebell, John P. Stein, Lillian Young, Shan-Rong Shi, Conway Gee, Susan Groshen, Donald G. Skinner, Richard J. Côté

    Julkaistu 2004
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers

    Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers Tekijä Aatur D. Singhi, Ben George, Joel Greenbowe, Jon Chung, James Suh, Anirban Maitra, Samuel J. Klempner, Andrew Hendifar, Javle Milind, Talia Golan, Randall E. Brand, Amer H. Zureikat, Somak Roy, Alexa B. Schrock, Vincent A. Miller, Jeffrey S. Ross, Siraj M. Ali, Nathan Bahary

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Open-label, Phase I Study of Nivolumab Combined with <i>nab</i>-Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer

    Open-label, Phase I Study of Nivolumab Combined with <i>nab</i>-Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer Tekijä Zev A. Wainberg, Howard S. Höchster, Edward Kim, Ben George, Aparna Kaylan, E. Gabriela Chiorean, David Waterhouse, Martin Guiterrez, Aparna R. Parikh, Rishi Jain, Daniel R. Carrizosa, Hatem Soliman, Thomas Lila, David J. Reiss, Daniel W. Pierce, Rafia Bhore, Sibabrata Banerjee, Larry Lyons, Chrystal U. Louis, Teng Jin Ong, Peter J. O’Dwyer

    Julkaistu 2020
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors

    Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors Tekijä Jeffrey M. Conroy, Sarabjot Pabla, Mary Nesline, Sean T. Glenn, Antonios Papanicolau‐Sengos, Blake Burgher, Jonathan Andreas, Vincent Giamo, Yirong Wang, Felicia L. Lenzo, Wiam Bshara, Maya Khalil, Grace K. Dy, Katherine G. Madden, Keisuke Shirai, Konstantin H. Dragnev, Laura J. Tafe, Jason Zhu, Matthew Labriola, Daniele Marin, Shannon J. McCall, Jeffrey Clarke, Daniel J. George, Tian Zhang, Matthew R. Zibelman, Pooja Ghatalia, Isabel Araujo-Fernandez, Luis de la Cruz‐Merino, Arun K. Singavi, Ben George, Alexander C. Mackinnon, Jonathan R. Thompson, Rajbir Singh, Robin Jacob, Deepa Kasuganti, Neel Shah, Roger Day, Lorenzo Galluzzi, Mark Gardner, Carl Morrison

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients

    Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients Tekijä Sarabjot Pabla, Jeffrey M. Conroy, Mary Nesline, Sean T. Glenn, Antonios Papanicolau‐Sengos, Blake Burgher, Jacob Hagen, Vincent Giamo, Jonathan Andreas, Felicia L. Lenzo, Yirong Wang, Grace K. Dy, Edwin Yau, Amy Early, Hongbin Chen, Wiam Bshara, Katherine G. Madden, Keisuke Shirai, Konstantin H. Dragnev, Laura J. Tafe, Daniele Marin, Jason Zhu, Jeff Clarke, Matthew Labriola, Shannon J. McCall, Tian Zhang, Matthew R. Zibelman, Pooja Ghatalia, Isabel Araujo-Fernandez, Arun K. Singavi, Ben George, Alexander C. Mackinnon, Jonathan R. Thompson, Rajbir Singh, Robin Jacob, Lynn Dressler, Mark Steciuk, Oliver A.R. Binns, Deepa Kasuganti, Neel Shah, Marc S. Ernstoff, Kunle Odunsi, Razelle Kurzrock, Mark Gardner, Lorenzo Galluzzi, Carl Morrison

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells

    DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells Tekijä Jiil Chung, Yosef E. Maruvka, Sumedha Sudhaman, Jacalyn Kelly, Nicholas J. Haradhvala, Vanessa Bianchi, Melissa Edwards, Victoria J. Forster, Nuno M. Nunes, Melissa A. Galati, Martin Komosa, Shriya Deshmukh, Vanja Cabric, Scott Davidson, Matthew Zatzman, Nicholas Light, Reid Hayes, Ledia Brunga, Nathaniel D. Anderson, Ben Ho, Karl P. Hodel, Robert Siddaway, A. Sorana Morrissy, Daniel C. Bowers, Valérie Larouche, Annika Bronsema, Michael Osborn, Kristina A. Cole, Enrico Opocher, Gary Mason, Gregory A. Thomas, Ben George, David S. Ziegler, Scott Lindhorst, Magimairajan Vanan, Michal Yalon-Oren, Alyssa Reddy, Maura Massimino, Patrick Tomboc, An Van Damme, Alexander Lossos, Carol Durno, Melyssa Aronson, Daniel A. Morgenstern, Éric Bouffet, Annie Huang, Michael D. Taylor, Anita Villani, David Malkin, Cynthia Hawkins, Zachary F. Pursell, Adam Shlien, Thomas A. Kunkel, Gad Getz, Uri Tabori

    Julkaistu 2020
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: